Live feed
Filing
SC 13D/A
SC 13D/A0001140361-19-010688·HALOZYME THERAPEUTICS, INC.
Schedule 13D ownership disclosure
HALOZYME THERAPEUTICS INC
Security class unavailable
Event date: 2019-06-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 12,111,874
- Percent of class
- 8.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-19-010688
- Form type
- SC 13D/A
- Filer
- HALOZYME THERAPEUTICS, INC.
- CIK
- CIK 1159036
- Filed
- Jun 07, 2019
- Reporting period
- Jun 06, 2019
- Description
- Schedule 13D beneficial ownership